Cochlear™ hearing solutions transform the lives of people with moderate to profound hearing loss. Yet globally, less than five percent of people who could benefit from this technology do so.
This is why Cochlear seeks to hire people who can embrace change, demonstrate a global mindset, promote innovation, and who are not afraid to push the limits.
"I love working at Cochlear because there are always new problems to solve."
– Steven Kennedy, Global Head of Regulatory Affairs
Where does Cochlear have career opportunities?
Founded and headquartered in Sydney, Australia, we have offices and operations around the world. This includes Cochlear Acoustics (Gothenburg, Sweden), and regional hubs for Cochlear Americas (Denver, USA), Cochlear Europe, Middle East and Africa (Basel, Switzerland), Cochlear Technology Centre (Mechelen, Belgium), Cochlear Asia Pacific (Sydney, Australia) and Cochlear Latin America and South America (Panama City, Panama).
This means there are global career opportunities in many business areas, including:
- Customer Service
- Finance and Accounting
- Information Technology
- Marketing and Communications
- Services Development
- Quality and Regulatory
- Clinical Affairs
- Research and Development
Careers in engineering
Want to help create products that bring positive change to people’s lives? Cochlear is always looking for people with engineering skills.
Graduates and students
Cochlear’s award-winning graduate program helps develop the engineering leaders of the future (Australian residents only).
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.